Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity. - Wikidata - wikimedia - TriplyDB

Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity.

Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity.

http://www.wikidata.org/entity/Q34491845

about

Cellular and molecular mechanisms of fibrosis Current status of vaccines for schistosomiasis A Player and Coordinator: The Versatile Roles of Eosinophils in the Immune System Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine Family Host responses in tissue repair and fibrosis Eosinophils in infection and intestinal immunity Inhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and Praziquantel Purinergic P2Y12 Receptor Activation in Eosinophils and the Schistosomal Host Response Pulmonary fibrosis: pathogenesis, etiology and regulation Evans blue staining reveals vascular leakage associated with focal areas of host-parasite interaction in brains of pigs infected with Taenia solium Mechanisms of fibrosis: therapeutic translation for fibrotic disease Cationic amino acid transporter-2 regulates immunity by modulating arginase activity.Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis Retnla (relmalpha/fizz1) suppresses helminth-induced Th2-type immunity.Egg antigen p40 of Schistosoma japonicum promotes senescence in activated hepatic stellate cells via SKP2/P27 signaling pathway.A longitudinal study of BCG vaccination in early childhood: the development of innate and adaptive immune responses.Macrophages and immunologic inflammation of the kidney.Macrophages: master regulators of inflammation and fibrosis.Interleukins in chronic liver disease: lessons learned from experimental mouse models Fat: a matter of disturbance for the immune system.Interleukin-13 Activates Distinct Cellular Pathways Leading to Ductular Reaction, Steatosis, and Fibrosis Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder.Parasites alter the pathological phenotype of lupus nephritis Integrating mechanisms of pulmonary fibrosis Th2-associated alternative Kupffer cell activation promotes liver fibrosis without inducing local inflammation.Schistosoma mansoni infection in eosinophil lineage-ablated mice.Granulocytes in helminth infection -- who is calling the shots?Protection against Acute Hepatocellular Injury Afforded by Liver Fibrosis Is Independent of T Lymphocytes.Immunopathology of schistosomiasis Upregulation of Toll-like receptor 2 and nuclear factor-kappa B expression in experimental colonic schistosomiasis Adipose tissue fibrosis in human cancer cachexia: the role of TGFβ pathway.Autoimmune Hepatitis in Brazilian Children: IgE and Genetic Polymorphisms in Associated Genes.Induction of alternatively activated macrophages enhances pathogenesis during severe acute respiratory syndrome coronavirus infection MyD88 signaling pathway is involved in renal fibrosis by favoring a TH2 immune response and activating alternative M2 macrophages.B cell response is required for granuloma formation in the early infection of Schistosoma japonicum.Protective immune mechanisms in helminth infection Tissue remodeling in eosinophilic esophagitis Cytokine and Chemokine Profile in Individuals with Different Degrees of Periportal Fibrosis due to Schistosoma mansoni Infection.Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation.Cytokine Pattern of T Lymphocytes in Acute Schistosomiasis mansoni Patients following Treated Praziquantel Therapy.

P2860

Q24648892-4331C92C-0E9D-4A92-ABE8-BA33E66FCAC0 Q24657733-D63E477B-AE57-4118-AB9E-7B45BD4F495E Q26745903-C0C690EC-48A6-4FAD-BAD7-550F48B100FC Q26801150-B112C9FE-BA08-42A0-9102-74911712C2F2 Q26852800-50BBCF99-1275-41B7-A5EB-B8EB1F99417E Q27028076-846B6E96-B6DE-473B-BC3A-B50B0E33D279 Q27304398-615019D9-58C2-4D0E-ABB1-02342EE25B35 Q27314997-BB88BD77-383A-4CBE-8AE8-6981BCBF6C2D Q28388425-5BDD006F-EB39-433A-837A-B380FBEB0E33 Q28539528-A81BFB2A-C249-44CC-969C-87C725290639 Q29620307-18C01EAB-DCCF-4B6F-A93D-4D9FC358EE42 Q33325920-C43DB314-57DE-49C7-9842-7C0FD639DE9C Q33429032-0C465418-A8F0-4E1B-B351-413306AF9C2E Q33432703-843E5916-CFBD-4895-AB55-EB302AE223BA Q33670909-6C7F335B-38F8-4650-9448-CC4273EB5BA8 Q33761119-FE82F96E-D13C-4715-91EF-8BE255B102C0 Q34067326-5678970D-2CF8-4206-B2ED-43F7055F5840 Q34076279-1864BAF9-B99C-4245-9C21-3F002C193242 Q34154258-6B651C9A-FC11-4888-99C5-D9FF45DDCB83 Q34200814-5AADF043-7E6E-4547-9352-F21556EF803E Q34534282-3E058521-8625-4069-95A3-B94139C74ED6 Q34674982-51385BB6-343A-4162-9C72-A4848FE453EF Q34700085-59A97241-1D9C-4CBA-A84B-E3B62FF32673 Q35106452-0AF04797-1909-4880-B2DF-5A6F6BACAFC9 Q35565153-73F43C28-BF8D-45D5-B016-1B99588176A7 Q35849182-16B584CD-170D-4581-986E-650F7F2F1AA1 Q36088115-B9A3298D-790E-42D8-B8AF-ACA866B7D3E2 Q36177168-00A1FAF7-6B71-43F3-BFDF-8BB327D253A7 Q36220509-43C8D8A6-FC4C-4A9F-AEB4-1D0AA33FEA61 Q36272303-87605F5C-E3A1-4F1B-9C8D-F6F37D56C7C1 Q36306603-738E4BE6-C8F0-42A8-BE6A-2EA8E131AA58 Q36360413-0216EF45-0631-4703-9253-0E345CB2272E Q36414300-C5F6875B-030C-4E47-90C3-774943501F38 Q36434363-22575AE1-94BF-49A5-A03D-FA5AF808569E Q36471300-061EB813-7323-46F0-870D-A50970D69A84 Q36481763-D5AF2A5C-3B5B-4C7A-A311-A332AC739429 Q36494364-17E9612B-5EB0-40CB-9783-30017C65384F Q36520002-1E2B6B7C-A70B-4A10-A3E8-0BD7ADBFBBF9 Q36579783-AEA3EF99-0C42-4882-A44E-F357DC0E94B9 Q36584302-3180F282-CCE0-4BB9-96FF-3DBF51F82D65

P2860

Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity.

http://www.wikidata.org/entity/Q34491845

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Interleukin-5 (IL-5) augments ...... by regulating IL-13 activity.

@ast

Interleukin-5 (IL-5) augments ...... by regulating IL-13 activity.

@en

Interleukin-5

@nl

type

label

Interleukin-5 (IL-5) augments ...... by regulating IL-13 activity.

@ast

Interleukin-5 (IL-5) augments ...... by regulating IL-13 activity.

@en

Interleukin-5

@nl

prefLabel

Interleukin-5 (IL-5) augments ...... by regulating IL-13 activity.

@ast

Interleukin-5 (IL-5) augments ...... by regulating IL-13 activity.

@en

Interleukin-5

@nl

P1433

Q34491845-9C0A1941-87D9-4E6A-9456-305D261C38BE

P1476

Q34491845-F2DC1279-970F-4C3E-9839-97B95B89B7B5

P2093

Q34491845-1A565A33-DDAD-486E-9358-4C6BB827621D

Q34491845-ABE56DE3-0447-4EC5-B0D3-13107EA9F64A

Q34491845-C6CF1E09-049A-4F29-9174-2489B45924FC

Q34491845-CE22A92C-B00C-47E6-A84D-5C7558D426E1

Q34491845-D13C7A0E-D6B6-4402-A1B4-15B254206A93

Q34491845-F6688F4F-221C-41C9-AA56-F3FD7F010EE3

Q34491845-F9AF0A92-14BB-4A12-A03B-90D3083E4BCF

P2860

Q34491845-0BADB705-3BA8-42CE-9BA4-933DF7D0E492

Q34491845-2131D8BC-4A2C-45BE-A4DD-B9023E402318

Q34491845-274751BB-B366-4120-A119-78142AAB0030

Q34491845-2B42A1B9-7F42-4C35-BC83-C5BD83087947

Q34491845-349CA032-3A09-49DC-9949-E93CCFCB0992

Q34491845-3533990F-E08F-46FE-892A-361CE28D18F5

Q34491845-3A803DDD-A717-447B-91C6-3B0D82949D8A

Q34491845-3E15DB0F-924D-492E-BE17-7B1AC0CE0028

Q34491845-5678C68E-300D-4DD2-923C-B4BF2AAD91B4

Q34491845-606CB3E0-5BAE-4920-A592-8CDB8AF3F443

P304

Q34491845-09DECDFB-797B-4727-848A-A465687DFBB3

P31

Q34491845-11E6034D-A9E4-408C-9A89-A0FEDDC9181E

P356

Q34491845-2DDB3246-648A-4AAD-9824-2397DDD72BB7

P407

Q34491845-E11D6D63-A410-4DA8-A598-6E7A77E94D11

P433

Q34491845-C3F64C14-00E3-49D5-9584-6F2AA713B436

P478

Q34491845-2F7AC2CD-EA9F-4BA5-A767-F746AD4C54B0

P50

Q34491845-43966991-D75E-4B3A-A563-77294E335B87

P5008

Q34491845-FFABD302-F945-4C91-87B4-7DA0330921FE

P577

Q34491845-4F0A525E-CC2D-409D-A4A8-6ED8411A594D

P698

Q34491845-4B22A4CB-A280-4A8C-913A-8CB33307D339

P921

Q34491845-e8d52aeb-6b72-48ef-9c94-c5523a7f6d88

P932

Q34491845-6099F636-3CB6-4D94-9320-C55DA1BD4D1D

P356

IAI.74.3.1471-1479.2006

P1433

Infection and Immunity

P1476

Interleukin-5 (IL-5) augments ...... s by regulating IL-13 activity

@en

P2093

Allen W Cheever

http://www.w3.org/2001/XMLSchema#string

Danielle Hari

http://www.w3.org/2001/XMLSchema#string

Helene F Rosenberg

http://www.w3.org/2001/XMLSchema#string

Rachael M Reiman

http://www.w3.org/2001/XMLSchema#string

Rachel Knight

http://www.w3.org/2001/XMLSchema#string

Robert W Thompson

http://www.w3.org/2001/XMLSchema#string

Thomas A Wynn

http://www.w3.org/2001/XMLSchema#string

P2860

Alternative activation of macrophages

IL-13 effector functions

Interleukin-5, eosinophils, and disease

Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand

Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cells

An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response.

Interleukin 5 (IL-5) is not required for expression of a Th2 response or host resistance mechanisms during murine schistosomiasis mansoni but does play a role in development of IL-4-producing non-T, non-B cells.

The immunobiology of schistosomiasis.

Dual function of eosinophils in pathogenesis and protective immunity against parasites.

Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis.

P304

1471-1479

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.74.3.1471-1479.2006

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16495517

http://www.w3.org/2001/XMLSchema#string

P921

P932

1418671

http://www.w3.org/2001/XMLSchema#string